Found 8 matching trials
A Through QT/QTc Study of KW-6356
PHASE1The purpose of this study is to evaluate the effects of multiple therapeuti...
Location
Medical Co. LTA Sumida Hospital
A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations
PHASE2The primary objective of this study is to determine the recommended dose an...
Location
Iwamizawa Neurology Clinic
A Drug Interaction Study of KW-6356 and Clarithromycin or Rifampicin
PHASE1The purpose of this study is to investigate the effects of CYP3A4/5 inhibit...
Location
Medical Co. LTA Sumida Hospital
A Drug Interaction Study of KW-6356 With Midazolam, Caffeine, or Rosuvastatin
PHASE1The purpose of this study is to evaluate the influence of repeated oral dos...
Location
Fukuoka Mirai Hospital Clinical Research Center
A Study of KW-6356 in Subjects With Early Parkinson's Disease
PHASE2The primary objective is to evaluate the effect of KW-6356 on motor symptom...
Location
Multiple Locations
Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-KW-6356
PHASE1This is an open-label, single-dose study in healthy male subjects to invest...
Location
Covance Clinical Research Unit Inc.
Single-dose Study to Investigate the Plasma PK of KW-6356 and Its Major Metabolite
PHASE1This is an open-label, non-randomized, single-dose study to investigate the...
Location
Clinical Pharmacology of Miami, LLC
A Study of Single and Multiple Doses of KW-6356 in Healthy Subjects
PHASE1Phase I study to assess the safety, tolerability and pharmacokinetics of si...
Location
Medical Co. LTA Sumida Hospital